The combined use of AZT and Nevirapine for the prevention of Mother-to-Child Transmission of HIV (PMTCT) has a lower risk of inducing antiretroviral resistance.

Simple item page
dc.contributor.authorVan Zyl GU
dc.contributor.authorClaassen M
dc.contributor.authorEngelbrecht S
dc.date.accessioned2012-08-10T18:17:34Z
dc.date.available2012-08-10T18:17:34Z
dc.date.issued2007
dc.descriptionPlease help us populate SUNScholar with the post print version of this article. It can be e-mailed to: scholar@sun.ac.za
dc.descriptionGeneeskunde
dc.descriptionGeneeskundige Virologie
dc.identifier.urihttp://hdl.handle.net/10019.1/41533
dc.titleThe combined use of AZT and Nevirapine for the prevention of Mother-to-Child Transmission of HIV (PMTCT) has a lower risk of inducing antiretroviral resistance.
dc.typeProceedings International
Files
Collections
2007 - Research Outputs